Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Infantile Respiratory Distress Syndrome in 106 studies

Research

Studies (106)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.89)18.7374
1990's88 (83.02)18.2507
2000's13 (12.26)29.6817
2010's3 (2.83)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, HY; Han, D; Jiang, H; Wu, HM; Wu, S; Yuan, LJ; Zhang, L; Zhao, S1
Lal, MK; Sinha, SK1
Moya, F1
Carlos, RQ; Davonzo, C; Dimaguila, MA; Gal, P; McPherson, C; Ransom, JL; Smith, M; Wimmer, JE1
Bahadue, FL; Soll, R1
Carlo, WA; St John, EB1
Bevilacqua, G; Parmigiani, S1
Bhutani, VK; Bowen, FW; Sivieri, EM1
Georgiev, GA; Georgieva, R; Iordanova, A; Khristova, E; Lalchev, Z; Petkova, Kh; Stoimenova, E; Todorov, R; Vasiliev, Kh1
Halliday, HL1
Easa, D; Long, W; Mullett, M; Schumacher, R; Sundell, H; Walther, FJ1
Cotton, R; Guthrie, R; Hirata, T; LeBlanc, M; Long, W; Mammel, M; Sell, M1
Beaumont, E; Cook, L; Dhanireddy, R; Gerdes, J; Gerdes, M; Jarret, R; Kopleman, A; Long, W1
Asbill, D; Bose, CL; Corbet, AJ; Edwards, K; Garcia-Prats, J; Kraybill, EN; Long, W1
Bard, H; Conway, B; Courtney, SE; Long, W; McMillan, D; Sauve, R; Thompson, T; Walter, D1
Corbet, A; Cotton, R; Gerdes, J; Long, W; Schumacher, R1
Bingham, W; Casiro, O; Long, W; MacMurray, B; Saigal, S; Vincer, M; Whitfield, M1
Bingham, W; Casiro, O; Long, W; MacMurray, B; Robertson, C; Saigal, S; Sankaran, K; Whitfield, M1
Anday, E; Boros, S; Bucciarelli, R; Burchfield, D; Gong, A; Long, W; Zucker, J1
Bard, H; Derleth, D; Long, W; Pauly, T; Robertson, C; Sauve, R; Stevenson, D; Vincer, M1
Allen, A; Long, W; MacMurray, B; Peliowski, A; Sankaran, K; Shukla, A; Smyth, J; Volberg, F1
Bard, H; Chernick, V; Finer, N; Krzeski, R; Long, W; McMillan, D; Schiff, D; Watts, J1
Avila, E; Cook, L; Corbet, A; Edwards, K; Gerdes, J; Long, W; Puri, A; Rosenberg, A1
Hamdan, AH; Shaw, NJ2
Laugier, J; Nashashibi, M; Nasr, C; Saliba, E; Vaillant, MC1
Kääpä, P; Kero, P; Seppänen, M1
Klein, JM; Patel, CA1
Bernstein, G; Cleary, JP; Heldt, GP; Mannino, FL1
Fuhrman, BP; Hernan, LJ; Holm, B; Leach, CL; Morin, FC; Papo, MC; Steinhorn, D1
Apere, H; Choukroun, ML; Demarquez, JL; Fayon, M; Galperine, RI; Guenard, H; Llanas, B1
Billman, D; Nicks, J; Schumacher, R1
Buck, R; Garland, J; Weinberg, M1
Soll, RF; Tarnow-Mordi, WO1
Cheah, IG; Lim, NL; Nordin, MM1
Gore, SM1
Robertson, B; Speer, CP1
Morley, C1
Tarnow-Mordi, W1
Hoffman, DR; Johnston, JM; Moya, FR; Zhao, B1
Glover, RM; Laing, IA; Parry, GJ; Stenson, BJ; Tarnow-Mordi, WO; Wilkie, RA1
Corkey, C; Jenkins, J; Rollins, M; Tubman, R; Wilson, D1
Ewing, CK; Richards, T; Sehgal, SS; Taeusch, HW1
Bourchier, D; Broadbent, R; Darlow, B; Knight, D; Selby, R; Wach, R1
Chan, JO; Darrow, KA; Kim, AH; Marks, KH; Moglia, BA; Reeves, IV; Seaton, JF1
Robertson, B; Sangstad, OD1
Bauer, CR; Fanaroff, AA; Fletcher, BD; Horbar, JD; Korones, SB; Oh, W; Shankaran, S; Soll, RF; Wright, EC; Wright, LL1
Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, S; Tooley, WH; Wakeley, A1
Bratlid, D; Farstad, T1
Abbasi, S; Bhutani, VK; Gerdes, JS1
Agarwal, R; Alba, J; Hegyi, T; Hiatt, IM1
Clarke, MP; Fritz, S; Pennefather, PM; Strong, NP; Tin, W1
Ishisaka, DY1
Claris, O; Grandjean, H; Hascoët, JM; Lenoir, S1
Auten, RL; Balsan, MJ; Belcastro, MR; Brody, AS; Buckwald, S; Carrion, V; Donohue, PK; Durand, DJ; Egan, EA; Farrell, EE; Graeber, JE; Horgan, MJ; Hudak, ML; Jansen, RD; Jung, AL; Laskay, KM; Maniscalco, WW; Martin, DJ; Matteson, EJ; Miller, RR; Montgomery, P; Riddlesberger, MM; Rosenberg, AA; Torres, BA1
Rogers, D1
Jeffery, HE; Skelton, R1
Bassiouny, MR; Cherian, E; Remo, C1
Santeiro, ML; Wyble, L1
Asselin, JM; Auten, RL; Belcastro, MR; Brody, AS; Cummings, NJ; Donohue, PK; Egan, EA; Hamm, CR; Hudak, ML; Jansen, RD; Jung, AL; Kimberlin, LV; Martin, DJ; Matteson, EJ; Montgomery, P; Riddlesberger, MM; Rosenberg, AA1
Cotton, RB; Lindstrom, DP; Parker, RA; Sandberg, KL; Sjöqvist, BA1
al-Essa, M; Dolovich, M; Fok, TF; Kirpalani, H; Rasid, F1
Kempley, ST; Murdoch, E2
John, E; Lloyd, J; Todd, DA1
Merchant, RH; Sanghvi, KP1
Al Khusaiby, SM; da Costa, DE; Pai, MG1
Soll, RF1
Beghetti, M; Berner, M; Hanquinet, S; Rimensberger, PC1
Halliday, HL; Robertson, B; Speer, CP1
Fellman, V; Ikonen, S; Järvenpää, AL; Kukkonen, AK; Pokela, ML; Virtanen, M1
Soll, RF; Suresh, GK1
Christodoulaki, M; Giannakopoulou, C; Hatzidaki, E; Korakaki, E; Mamoulakis, D; Margari, KM1
Galan, HL; Kuehl, TJ1
Balaraman, V; Barrett, J; Easa, D; Ibarra-Pratt, E; Loo, SW; Nakamura, KT; Pelke, S; Smith, MB1
Ariagno, RL; Armsby, DH; Baldwin, R; Bellon, G; Carlisle, K; Long, W; Rector, D; Stevenson, DK1
King, M; Ramirez, O; Rubin, BK1
Bhatt-Mehta, V; Schumacher, RE1
Cummings, JJ; Egan, EA; Ferguson, WH; Holm, BA; Hudak, BB; Hudak, ML1
Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE1
Sekar, KC; Toubas, PL; Wallenbrock, MA1
Bose, G1
Dechant, KL; Faulds, D1
Abbasi, S; Bhutani, VK; Gerdes, JS; Long, WA1
Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F1
Bard, H; Bourgeois, M; Chessex, P; Hazan, J; Long, W; Piedboeuf, B1
Gerdes, J; Long, W; Whitsett, J1
Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D1
Prevost, RR1
Edwards, DK; Levine, D; Merritt, TA1
Bard, H; Chernick, V; Corbet, A; Cotton, R; Courtney, S; Long, W; McGuiness, G; Smyth, J; Walter, D; Watts, J1
Corbet, AJ; Garcia-Prats, JA; Lombardy, LR; Long, WA; Murphy, DJ; Wold, DE1
Bucciarelli, R; Corbet, A; Goldman, S; Long, W; Mammel, M; Wold, D1
Ma, EJ; van de Bor, M; Walther, FJ1
Guthrie, R; Long, W; Schumacher, R; Sundell, H; Thompson, T; Volberg, F1
Nightingale, SL1
Bose, C; Bose, G; Corbet, A; Donlon, D; Garcia-Prats, J; Lombardy, L; Long, W; Wold, D1
Brown, CL; Clements, JA; Muramatsu, K; Schlueter, MA; Tooley, WH1
Ballard, P; Clements, JA; Clyman, RI; Durand, DJ; Heymann, MA; Kitterman, J; Mauray, F1

Reviews

10 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome

ArticleYear
Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 34

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Phosphatidylglycerols; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn

2015
Surfactant respiratory therapy using Surfaxin/sinapultide.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Peptides; Phosphatidylglycerols; Phosphorylcholine; Polyethylene Glycols; Polymyxin B; Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Treatment Outcome

2008
Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.
    Journal of perinatology : official journal of the California Perinatal Association, 2009, Volume: 29 Suppl 2

    Topics: Animals; Biological Products; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Drug Combinations; Evidence-Based Medicine; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Newborn; Intensive Care, Neonatal; Phosphatidylglycerols; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Proteins; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome

2009
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11

    Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Time Factors

2012
Overview of clinical trials comparing natural and synthetic surfactants.
    Biology of the neonate, 1995, Volume: 67 Suppl 1

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn

1995
Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing?
    European journal of pediatrics, 1994, Volume: 153, Issue:9 Suppl 2

    Topics: Biological Products; Clinical Trials as Topic; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1994
Exogenous surfactant use in neonates.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:4

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1996
Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

2000
Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
    Pediatric pulmonology, 1992, Volume: 14, Issue:4

    Topics: Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Lung Compliance; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Gas Exchange; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors

1992
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991

Trials

68 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome

ArticleYear
Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Biology of the neonate, 2005, Volume: 87, Issue:4

    Topics: Continuous Positive Airway Pressure; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Longitudinal Studies; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Retrospective Studies

2005
One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Hospitalization; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Nervous System Diseases; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Newborn; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Gro
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity

1995
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1995
Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate

1995
Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1995
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    The Journal of pediatrics, 1995, Volume: 126, Issue:6

    Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Enterocolitis, Pseudomembranous; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

1995
Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
    Archives of disease in childhood. Fetal and neonatal edition, 1994, Volume: 71, Issue:3

    Topics: Blood Flow Velocity; Blood Pressure; Brain; Cerebrovascular Circulation; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Heart; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Instillation, Drug; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1994
Improved oxygenation during synchronized intermittent mandatory ventilation in neonates with respiratory distress syndrome: a randomized, crossover study.
    The Journal of pediatrics, 1995, Volume: 126, Issue:3

    Topics: Carbon Dioxide; Combined Modality Therapy; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Intermittent Positive-Pressure Ventilation; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome

1995
Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant.
    The Journal of pediatrics, 1995, Volume: 126, Issue:3

    Topics: Animals; Animals, Newborn; Biological Products; Combined Modality Therapy; Drug Combinations; Emulsions; Fatty Alcohols; Fluorocarbons; Humans; Hydrocarbons, Brominated; Infant, Newborn; Oxygen; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Random Allocation; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep

1995
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Pediatric pulmonology, 1994, Volume: 18, Issue:5

    Topics: Airway Resistance; Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung Compliance; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Mechanics; Time Factors

1994
Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
    Pediatric pulmonology, 1994, Volume: 18, Issue:5

    Topics: Airway Resistance; Blood Gas Analysis; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Circulation; Pulmonary Gas Exchange; Pulmonary Surfactants; Regression Analysis; Respiration; Respiratory Distress Syndrome, Newborn; Time Factors

1994
Surfactant therapy in respiratory distress syndrome--the first local experience.
    The Medical journal of Malaysia, 1994, Volume: 49, Issue:1

    Topics: Cause of Death; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Length of Stay; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Pilot Projects; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome

1994
OSIRIS trial.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Adrenal Cortex Hormones; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1993
OSIRIS trial.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Brain Diseases; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ultrasonography

1993
OSIRIS trial.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant Mortality; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1993
OSIRIS trial.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Diagnostic Errors; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Respiratory Distress Syndrome, Newborn

1993
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Archives of disease in childhood. Fetal and neonatal edition, 1994, Volume: 70, Issue:1

    Topics: Animals; Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Lung Compliance; Male; Oxygen; Partial Pressure; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Swine

1994
Comparison of clinical responses to natural and synthetic surfactants.
    Journal of perinatal medicine, 1993, Volume: 21, Issue:5

    Topics: Arteries; Biological Products; Cerebral Hemorrhage; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

1993
Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Journal of the National Medical Association, 1994, Volume: 86, Issue:1

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Pilot Projects; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1994
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    The New Zealand medical journal, 1994, Jun-22, Volume: 107, Issue:980

    Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohols; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; New Zealand; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Prenatal Care; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Steroids; Survival Rate; Ultrasonography

1994
Cardiorespiratory and stress hormone responses during first dose surfactant administration in neonates with RDS.
    Pediatric pulmonology, 1994, Volume: 17, Issue:4

    Topics: Biological Products; Blood Pressure; Catecholamines; Drug Combinations; Fatty Alcohols; Hemodynamics; Humans; Infant, Newborn; Oxygen; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Sympathetic Nervous System

1994
A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
    The Journal of pediatrics, 1993, Volume: 123, Issue:5

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Mechanics; Treatment Outcome

1993
Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
    The Journal of pediatrics, 1993, Volume: 123, Issue:6

    Topics: Costs and Cost Analysis; Drug Combinations; Fatty Alcohols; Female; Hospital Costs; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Regression Analysis; Respiratory Distress Syndrome, Newborn

1993
[Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1994, Jan-10, Volume: 114, Issue:1

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature, Diseases; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1994
Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
    The Journal of pediatrics, 1993, Volume: 122, Issue:3

    Topics: Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Treatment Outcome

1993
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics, 1996, Volume: 97, Issue:1

    Topics: Biological Products; Chronic Disease; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk

1996
Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
    The British journal of ophthalmology, 1996, Volume: 80, Issue:5

    Topics: Drug Combinations; England; Fatty Alcohols; Female; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity; Survival Analysis

1996
Exogenous surfactant use in neonates.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:4

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1996
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    The Journal of pediatrics, 1996, Volume: 128, Issue:3

    Topics: Bronchopulmonary Dysplasia; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Incidence; Infant, Newborn; Length of Stay; Linear Models; Phosphorylcholine; Pneumothorax; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Time Factors; Treatment Outcome

1996
Factors affecting the neonatal response to artificial surfactant.
    Journal of paediatrics and child health, 1996, Volume: 32, Issue:3

    Topics: Administration, Inhalation; Analysis of Variance; Chi-Square Distribution; Drug Combinations; Evaluation Studies as Topic; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome

1996
Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Journal of tropical pediatrics, 1997, Volume: 43, Issue:1

    Topics: Algorithms; Biological Products; Blood Gas Analysis; Drug Combinations; Fatty Alcohols; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1997
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Pediatrics, 1997, Volume: 100, Issue:1

    Topics: Age Factors; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Data Interpretation, Statistical; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Linear Models; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome

1997
Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
    Pediatric pulmonology, 1997, Volume: 24, Issue:5

    Topics: Analysis of Variance; Biological Products; Breath Tests; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Linear Models; Nitrogen; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Gas Exchange; Pulmonary Surfactants; Pulmonary Ventilation; Respiratory Distress Syndrome, Newborn

1997
Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group.
    American journal of obstetrics and gynecology, 1998, Volume: 178, Issue:1 Pt 1

    Topics: Adrenal Cortex Hormones; Adult; Betamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Fetus; Humans; Incidence; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Maternal Welfare; Phosphorylcholine; Polyethylene Glycols; Pregnancy; Pregnancy Outcome; Prolactin; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Thyroid Hormones; Thyrotropin-Releasing Hormone

1998
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Pediatric pulmonology, 1998, Volume: 25, Issue:3

    Topics: Acceleration; Biological Products; Birth Weight; Blood Pressure; Cardiac Output; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Inhalation; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pressure; Pulmonary Artery; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Ultrasonography, Doppler; Ventricular Function, Right

1998
Randomized trial examining cerebral haemodynamics following artificial or animal surfactant.
    Acta paediatrica (Oslo, Norway : 1992), 1998, Volume: 87, Issue:4

    Topics: Biological Products; Cerebral Arteries; Cerebrovascular Circulation; Drug Combinations; Fatty Alcohols; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Intermittent Positive-Pressure Ventilation; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Regional Blood Flow; Respiratory Distress Syndrome, Newborn; Statistics, Nonparametric

1998
Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
    Early human development, 1999, Volume: 54, Issue:2

    Topics: Analysis of Variance; Biological Products; Chi-Square Distribution; Chromatography, Thin Layer; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome

1999
Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Indian pediatrics, 1998, Volume: 35, Issue:6

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Lipids; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Analysis

1998
Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    Pediatric pulmonology, 1999, Volume: 27, Issue:5

    Topics: Biological Products; Blood Gas Analysis; Developing Countries; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Oman; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Survival Rate; Treatment Outcome

1999
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Acta paediatrica (Oslo, Norway : 1992), 2000, Volume: 89, Issue:5

    Topics: Biological Products; C-Reactive Protein; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Leukopenia; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk; Sepsis; Thrombocytopenia

2000
The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
    European journal of pediatrics, 2000, Volume: 159, Issue:10

    Topics: Biological Products; Birth Weight; Diuresis; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Infant, Premature; London; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome; Water-Electrolyte Balance

2000
Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome.
    Pediatrics international : official journal of the Japan Pediatric Society, 2002, Volume: 44, Issue:2

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

2002
Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    The Online journal of current clinical trials, 1992, Nov-10, Volume: Doc No 28

    Topics: Brain Diseases; Cysts; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Ultrasonography

1992
Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
    Lancet (London, England), 1992, Dec-05, Volume: 340, Issue:8832

    Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk Factors; Treatment Outcome

1992
Surfactant for babies.
    Lancet (London, England), 1992, Dec-05, Volume: 340, Issue:8832

    Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
    Pediatric pulmonology, 1992, Volume: 14, Issue:1

    Topics: Drug Administration Schedule; Drug Combinations; Drugs, Investigational; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies

1992
Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
    Chest, 1992, Volume: 101, Issue:4

    Topics: Drug Combinations; Elasticity; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Mucociliary Clearance; Mucus; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Rheology; Viscosity

1992
Turnover of exogenous artificial surfactant.
    Archives of disease in childhood, 1992, Volume: 67, Issue:4 Spec No

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Intubation, Intratracheal; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    The Journal of pediatrics, 1992, Volume: 120, Issue:2 Pt 2

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Respiratory Mechanics

1992
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1992, Volume: 120, Issue:2 Pt 2

    Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis

1992
Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome.
    The Journal of pediatrics, 1992, Volume: 120, Issue:2 Pt 2

    Topics: Calorimetry, Indirect; Drug Combinations; Energy Metabolism; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
    The Journal of pediatrics, 1992, Volume: 120, Issue:2 Pt 2

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Pancreatic Elastase; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea

1992
Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    The Journal of pediatrics, 1992, Volume: 120, Issue:2 Pt 2

    Topics: Autopsy; Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    The New England journal of medicine, 1991, Dec-12, Volume: 325, Issue:24

    Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ventilator Weaning

1991
Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
    Journal of paediatrics and child health, 1991, Volume: 27, Issue:4

    Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Follow-Up Studies; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
    The Journal of pediatrics, 1991, Volume: 118, Issue:2

    Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate

1991
Cerebral blood flow velocity after surfactant instillation in preterm infants.
    The Journal of pediatrics, 1991, Volume: 118, Issue:2

    Topics: Blood Flow Velocity; Cerebral Hemorrhage; Cerebrovascular Circulation; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    The Journal of pediatrics, 1991, Volume: 118, Issue:4 Pt 1

    Topics: Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Outcome and Process Assessment, Health Care; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    The Journal of pediatrics, 1990, Volume: 117, Issue:6

    Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate

1990

Other Studies

30 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome

ArticleYear
Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
    Pediatric cardiology, 2010, Volume: 31, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Biological Products; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ductus Arteriosus, Patent; Echocardiography; Echocardiography, Doppler, Color; Fatty Alcohols; Guideline Adherence; Humans; Indomethacin; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Metabolic Clearance Rate; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

2010
Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network.
    Seminars in perinatology, 2003, Volume: 27, Issue:4

    Topics: Adrenal Cortex Hormones; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; National Institutes of Health (U.S.); Oxygen; Phosphorylcholine; Polyethylene Glycols; Pregnancy; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Treatment Outcome; United States

2003
An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2003, Volume: 14, Issue:3

    Topics: Biological Products; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Italy; Lipids; Oxygen Inhalation Therapy; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Time Factors; Treatment Outcome

2003
[Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Akusherstvo i ginekologiia, 2007, Volume: 46 Suppl 1

    Topics: Animals; Biological Products; Biophysical Phenomena; Biophysics; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lipids; Models, Biological; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Surface Tension

2007
Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
    Archives of disease in childhood. Fetal and neonatal edition, 1995, Volume: 72, Issue:3

    Topics: Acute Disease; Blood Pressure; Drug Combinations; Echocardiography, Doppler; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Artery; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1995
Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
    American journal of perinatology, 1994, Volume: 11, Issue:6

    Topics: Blood Flow Velocity; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Circulation; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Suction; Ultrasonography, Doppler

1994
Outcome of infants with birth weights less than 1000 g with respiratory distress syndrome treated with high-frequency ventilation and surfactant replacement therapy.
    Archives of pediatrics & adolescent medicine, 1995, Volume: 149, Issue:3

    Topics: Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; High-Frequency Ventilation; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Treatment Outcome

1995
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
    Pediatrics, 1994, Volume: 94, Issue:5

    Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retrospective Studies

1994
Platelet-activating factor in surfactant preparations.
    Lancet (London, England), 1993, Apr-03, Volume: 341, Issue:8849

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipases A; Phospholipids; Phosphorylcholine; Platelet Activating Factor; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea

1993
[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1994, Feb-20, Volume: 114, Issue:5

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1994
Efficacy of surfactant therapy in infants managed with CPAP.
    Pediatric pulmonology, 1995, Volume: 20, Issue:3

    Topics: Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1995
[Outcome of blood gas parameters during the first 24 years after Exosurf administration].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:4

    Topics: Analysis of Variance; Blood Gas Analysis; Cohort Studies; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors

1996
Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
    Archives of disease in childhood. Fetal and neonatal edition, 1996, Volume: 74, Issue:2

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Wedge Pressure; Respiratory Distress Syndrome, Newborn

1996
Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:6

    Topics: Biological Products; Drug Combinations; Drug Costs; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome

1997
Nebulisation of surfactants in an animal model of neonatal respiratory distress.
    Archives of disease in childhood. Fetal and neonatal edition, 1998, Volume: 78, Issue:1

    Topics: Aerosols; Animals; Biological Products; Carbon Dioxide; Disease Models, Animal; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung; Nebulizers and Vaporizers; Oxygen; Partial Pressure; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn

1998
First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome.
    Pediatrics, 2000, Volume: 105, Issue:6

    Topics: Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome

2000
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Acta paediatrica (Oslo, Norway : 1992), 2000, Volume: 89, Issue:5

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Risk; Sepsis

2000
Current surfactant use in premature infants.
    Clinics in perinatology, 2001, Volume: 28, Issue:3

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome

2001
[Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1992, Volume: 140, Issue:9 [EXOSURF

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Obstetrics and gynecology, 1992, Volume: 80, Issue:4

    Topics: Amnion; Animals; Animals, Newborn; Drug Combinations; Fatty Alcohols; Fetus; Gestational Age; Humans; Infant, Newborn; Injections; Lung; Organ Size; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn

1992
Criteria for use of colfosceril (Exosurf) in neonates.
    Clinical pharmacy, 1992, Volume: 11, Issue:4

    Topics: Apnea; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Newborn; Intubation, Intratracheal; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

1992
A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.
    The American review of respiratory disease, 1992, Volume: 145, Issue:5

    Topics: Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep

1992
Prediction of the acute response to surfactant therapy by pulmonary function testing.
    Pediatric pulmonology, 1992, Volume: 13, Issue:1

    Topics: Airway Resistance; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Compliance; Phosphorylcholine; Polyethylene Glycols; Predictive Value of Tests; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests

1992
Surfactant replacement therapy: issues related to currently available preparations.
    Neonatal network : NN, 1992, Volume: 11, Issue:4

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Maternal-Child Nursing; Monitoring, Physiologic; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Comparing surfactant products.
    Clinical pharmacy, 1991, Volume: 10, Issue:12

    Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    AJR. American journal of roentgenology, 1991, Volume: 157, Issue:2

    Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Radiography, Thoracic; Respiratory Distress Syndrome, Newborn

1991
Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug and therapeutics bulletin, 1991, Jun-10, Volume: 29, Issue:12

    Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
From the Food and Drug Administration.
    JAMA, 1990, Oct-10, Volume: 264, Issue:14

    Topics: Chronic Disease; Diet Fads; Dietary Fiber; Drug Combinations; Esophageal Stenosis; Fatty Alcohols; Fentanyl; Galactans; Humans; Infant, Low Birth Weight; Infant, Newborn; Mannans; Pain; Phosphorylcholine; Plant Gums; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; United States; United States Food and Drug Administration

1990
Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
    The American review of respiratory disease, 1987, Volume: 136, Issue:3

    Topics: Animals; Drug Combinations; Fatty Alcohols; Infant, Newborn; Lung; Lung Compliance; Lung Volume Measurements; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Gas Exchange; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn

1987
Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs.
    The Journal of pediatrics, 1985, Volume: 107, Issue:5

    Topics: Animals; Animals, Newborn; Drug Combinations; Fatty Alcohols; Fetal Organ Maturity; Humans; Infant, Newborn; Lung; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep

1985